c-Jun N-terminal Kinase Enhances MST1-mediated Pro-apoptotic Signaling through Phosphorylation at Serine 82

被引:62
|
作者
Bi, Wenzhi [2 ]
Xiao, Lei [1 ]
Jia, Yunfeng [3 ]
Wu, Junbing [1 ]
Xie, Qi [1 ]
Ren, Jian [1 ]
Ji, Guangju [1 ]
Yuan, Zengqiang [1 ]
机构
[1] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Clin Div Surg, Dept Orthoped, Beijing 100853, Peoples R China
[3] Chinese PLA 306 Hosp, Dept Neurosurg, Beijing 100101, Peoples R China
基金
美国国家科学基金会;
关键词
STE20-LIKE PROTEIN-KINASE; CELL-DEATH MACHINERY; PROMOTES APOPTOSIS; JNK PHOSPHORYLATION; STERILE-20; KINASE; HISTONE H2B; MST1; ACTIVATION; CASPASE; PATHWAY;
D O I
10.1074/jbc.M109.038570
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinases play an important role in the maintenance of homeostasis between cell survival and apoptosis. Deregulation of these kinases leads to various pathological manifestations, such as cancer and neurodegenerative diseases. The MST1 encodes a serine/threonine kinase that is activated upon apoptotic stimulation, which in turn phosphorylates its downstream targets, Histone H2B and FOXO. However, the upstream regulators of MST1 kinase have been poorly studied. In this study, we report that JNK (c-Jun N-terminal kinase) phosphorylates MST1 at serine 82, which leads to the enhancement of MST1 activation. Accordingly, the activation of MST1 phosphorylates FOXO3 at serine 207 and promotes cell death. The inhibition of JNK kinase per se attenuates MST1 activity and nuclear translocation as well as MST1-induced apoptosis. We also find the S82A (serine mutated to alanine) diminishes MST1 activation and its effect on the FOXO transcription activity. Collectively, these findings define the novel feedback regulation of MST1 kinase activation by its putative substrate, JNK, with implication for our understanding of the signaling mechanism during cell death.
引用
收藏
页码:6259 / 6264
页数:6
相关论文
共 50 条
  • [21] Synthesis-accessibility-oriented design of c-Jun N-terminal kinase 1 inhibitor
    Qian, Hewen
    Ding, Yuanqing
    Deng, Xingyu
    Huang, Weiwei
    Li, Zhenzhen
    Liu, Fengling
    Zhang, Jie
    Wang, Lihui
    Liu, Junping
    Yuan, Yaxia
    Hou, Shurong
    Chen, Xiabin
    Ma, Lei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 256
  • [22] c-Jun N-Terminal Kinase Mediated VEGFR2 Sustained Phosphorylation is Critical for VEGFA-Induced Angiogenesis In Vitro and In Vivo
    Shen, Kaikai
    Ji, Lili
    Lu, Bin
    Wang, Zhengtao
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2012, 64 (01) : 17 - 27
  • [23] Hepatotoxicity Mediated by Pyrazole (Cytochrome P450 2E1) Plus Tumor Necrosis Factor Alpha Treatment Occurs in c-Jun N-terminal kinase 2-/- but Not in c-Jun N-terminal kinase 1-/- Mice
    Wang, Xiaodong
    Wu, Defeng
    Yang, Lili
    Cederbaum, Arthur I.
    HEPATOLOGY, 2011, 54 (05) : 1753 - 1766
  • [24] Superior cervical ganglion-10 protein as a molecular effector of c-Jun N-terminal kinase 1: implications for the therapeutic targeting of Jun N-terminal kinase in nerve regeneration
    Westerlund, Nina
    Zdrojewska, Justyna
    Courtney, Michael J.
    Coffey, Eleanor T.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (01) : 31 - 43
  • [25] c-Jun N-terminal kinase-mediated anti-inflammatory effects of Garcinia subelliptica in macrophages
    Cho, Young-Chang
    Cho, Sayeon
    MOLECULAR MEDICINE REPORTS, 2016, 13 (03) : 2293 - 2300
  • [26] Pirfenidone attenuates acetaminophen-induced liver injury via suppressing c-Jun N-terminal kinase phosphorylation
    Tashiro, Shigeki
    Tanaka, Masatake
    Goya, Takeshi
    Aoyagi, Tomomi
    Kurokawa, Miho
    Imoto, Koji
    Kuwano, Akifumi
    Takahashi, Motoi
    Suzuki, Hideo
    Kohjima, Motoyuki
    Kato, Masaki
    Ogawa, Yoshihiro
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2022, 434
  • [27] Phosphorylation of JDP2 on threonine-148 by the c-Jun N-terminal kinase targets it for proteosomal degradation
    Weidenfeld-Baranboim, Keren
    Koren, Lilach
    Aronheim, Ami
    BIOCHEMICAL JOURNAL, 2011, 436 : 661 - 669
  • [28] Structure Optimization of c-Jun N-terminal Kinase 1 Inhibitors for Treating Idiopathic Pulmonary Fibrosis
    Huang, Yi
    Liu, Fengling
    Ren, Shuhua
    Ding, Yuanqing
    Chi, Man
    Huang, Weiwei
    Gu, Wenjing
    Qian, Hewen
    Yuan, Yaxia
    Hou, Shurong
    Chen, Xiabin
    Ma, Lei
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (19) : 17713 - 17737
  • [29] Involvement of c-Jun N-terminal kinase and extracellular signal-regulated kinase 1/2 in EGF-induced angiogenesis
    Shen, Kaikai
    Sheng, Yuchen
    Ji, Lili
    Wang, Zhengtao
    CELL BIOLOGY INTERNATIONAL, 2010, 34 (12) : 1213 - 1218
  • [30] AKT/mTOR and c-Jun N-terminal kinase signaling pathways are required for chrysotile asbestos-induced autophagy
    Lin, Ziying
    Liu, Tie
    Kamp, David W.
    Wang, Yahong
    He, Huijuan
    Zhou, Xu
    Li, Donghong
    Yang, Lawei
    Zhao, Bin
    Liu, Gang
    FREE RADICAL BIOLOGY AND MEDICINE, 2014, 72 : 296 - 307